The encyclopedia · Advertising & PR · Marketing decision · 2023–2025
Five Doctors' vulgar elevator ad was fined ¥400k — the apology changed nothing
'Hubby made me mad, drink!' — fined ¥400k. The apology came that night; the same ads and worse claims kept running, and the fines kept coming.
Five Doctors · Beijing Qingyan Boshi Health Management · 2023-06
What happened
Five Doctors (Wuge Nvboshi) is a Chinese collagen-peptide drink brand founded in 2019 on the story of five female medical PhDs from Peking University. Peking University Health Science Center publicly disclaimed the brand in September 2020, saying it had no investment or technology-transfer relationship with the company. The brand grew fast on Douyin anyway: second in the platform's tonic-category sales during the 2022 618 festival, with actress Li Ruotong as its ambassador.
In May 2023 the brand's elevator ad went viral for the wrong reasons. Five doctors in white coats answered everyday complaints — 'Hubby made me mad, drink! Binge-watching till 2am, drink! A year older, drink!' — in a register viewers called flirtatious, and complaints piled up that the campaign was vulgar and demeaned women. On 14 June 2023, Beijing's Chaoyang district market regulator ruled it violated Article 9 of the Advertising Law — disturbing public order or offending good social customs — ordered it pulled, and fined the brand company ¥400,000.
The brand apologized the same night — 'we accept the penalty wholeheartedly and will rectify resolutely' — and the penalty record kept growing regardless. In April 2024, Shanghai's market regulator fined the campaign's publisher, Shanghai Dingxiang Advertising, ¥200,000 over the same elevator ads. In July 2025, a brand distributor was penalized by the Boshan district regulator in Zibo for false advertising on JD.com: claims like 'source-level protection against collagen loss' and 'meets the food-safety standards of 47 countries' that it could not substantiate.
The Paper found the brand's core product is an ordinary beverage under the GB7101 national standard, while its livestream rooms kept citing efficacy figures — 'skin gloss up 81.19%, fine-line volume down 20.76%' — with a line of fine print disclaiming them. By late May 2026, consumer allergy complaints put the brand on Weibo's trending list, and the Black Cat complaint platform carried 121 complaints naming it. Sales were never the problem: 717,000 units sold on Douyin by June 2023, and the brand kept topping e-commerce oral-beauty rankings through 2026.
Why it happened
- The marketing needed a health claim the product was not licensed to make, so every campaign that worked was a campaign that broke the rule — the fines were not accidents, they were the format
- The fine is a rounding error: ¥400k against a Douyin store doing 700k+ orders. When a penalty costs less than the campaign's sales lift, compliance loses every cost-benefit comparison.
- The apology is scripted as crisis PR, not as the start of a change — issued the same night, worded to close the news cycle, with no structural follow-up anyone could verify.
- Penalties land on scattered legal entities — the brand company, the ad publisher, a distributor — while the marketing strategy that produces the ads is never itself the penalized party.
- The PhD-doctor persona is the brand's core asset: the efficacy hints work because of the white coats, so the brand cannot drop the register without dropping the pitch.
The lesson
When a fine is smaller than the sales an ad drives, the apology becomes a line item. Regulators penalized the publisher and the distributor, never the strategy — so the strategy outlived every fine.
Aftermath
The pattern predates the elevator ads: in August 2022 a related company was fined ¥1,500 for Douyin promotions using 'anti-inflammatory' and other disease-treatment terms. Three more penalties followed in two years, each with an apology and none with a change of model. The brand's registered capital was cut from ¥31.5M to ¥18M in September 2025 even as cumulative sales passed 500 million bottles, and it kept leading the oral-beauty category through the 2026 618 promotion.
Sources
spotted an error? The club wants to know.
More like this
A snack brand called itself 'nationwide No.1 in sales' on a survey nobody could check
Haihe Milk's livestream host used sexual innuendo to sell milk
A Guilin bakery turned a nearby earthquake into a '520' promotion
Somewhere, someone solved the problem this company failed at. 2nd Opinion →
Comments · 0
Sign in to join the comments.